Author:
Loganathan Tamizhini,Fletcher John,Abraham Priya,kannangai Rajesh,Chakraborty Chiranjib,El Allali Achraf,Alsamman Alsamman M.,Zayed Hatem,C George Priya Doss
Abstract
Abstract
Background
Monkeypox (Mpox) is an important human pathogen without etiological treatment. A viral-host interactome study may advance our understanding of molecular pathogenesis and lead to the discovery of suitable therapeutic targets.
Methods
GEO Expression datasets characterizing mRNA profile changes in different host responses to poxviruses were analyzed for shared pathway identification, and then, the Protein–protein interaction (PPI) maps were built. The viral gene expression datasets of Monkeypox virus (MPXV) and Vaccinia virus (VACV) were used to identify the significant viral genes and further investigated for their binding to the library of targeting molecules.
Results
Infection with MPXV interferes with various cellular pathways, including interleukin and MAPK signaling. While most host differentially expressed genes (DEGs) are predominantly downregulated upon infection, marked enrichments in histone modifiers and immune-related genes were observed. PPI analysis revealed a set of novel virus-specific protein interactions for the genes in the above functional clusters. The viral DEGs exhibited variable expression patterns in three studied cell types: primary human monocytes, primary human fibroblast, and HeLa, resulting in 118 commonly deregulated proteins. Poxvirus proteins C6R derived protein K7 and K7R of MPXV and VACV were prioritized as targets for potential therapeutic interventions based on their histone-regulating and immunosuppressive properties. In the computational docking and Molecular Dynamics (MD) experiments, these proteins were shown to bind the candidate small molecule S3I-201, which was further prioritized for lead development.
Results
MPXV circumvents cellular antiviral defenses by engaging histone modification and immune evasion strategies. C6R-derived protein K7 binding candidate molecule S3I-201 is a priority promising candidate for treating Mpox.
Publisher
Springer Science and Business Media LLC
Reference90 articles.
1. Haller SL, Peng C, McFadden G, Rothenburg S. Poxviruses and the evolution of Host Range and Virulence. Infect Genet Evol. 2014;21:15–40.
2. Alcami A, Koszinowski UH. Viral mechanisms of immune evasion. Immunol Today. 2000;21:447–55.
3. Tiecco G, Degli Antoni M, Storti S, Tomasoni LR, Castelli F, Quiros-Roldan E. Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From? Viruses. 2022;14:1894.
4. CDC. Mpox in the U.S. Centers for Disease Control and Prevention. 2023. https://www.cdc.gov/poxvirus/mpox/response/2022/index.html.
5. Wikipedia Contributors. 2022–2023 mpox outbreak in India. Wikipedia. 2024. https://en.wikipedia.org/wiki/2022%E2%80%932023_mpox_outbreak_in_India. Accessed 16 Feb 2024.